Covered are new reimbursement proposals, approvable drugs, new technology items, and other issues
Stopping SSRIs, SNRIs During Pregnancy Not Linked to Adverse Psychiatric Outcomes
Discontinuing SSRIs or SNRIs during pregnancy did not lead to an increase in hospitalizations, outpatient visits, suicidal behavior, or sick leave use.
What is Being Done to Address Pharmacy Deserts in the US?
Cencora representatives with expertise into pharmacy desert insights joined Drug Topics to discuss issues in pharmacy access and what is being done to address them.
Tandem’s Automated Insulin Delivery Technology Shows Improved Outcomes in T2D
Control-IQ+ was associated with a greater reduction in glycated hemoglobin compared to a continuous glucose monitor alone.
What Does the Future of Pain Medicine Look Like?
With minimal pharmacological treatments coming to market for chronic pain, researchers have explored new technologies for advancing pain treatment across the globe.
Q&A: Expert Discusses Trust Building in Community Pharmacy During COVID-19 Pandemic
Jade Ranger, PharmD, co-owner and pharmacist at the Prescription Shoppe, discussed administering vaccines during the COVID-19 pandemic.
CGM Could Help Management of Diabetic Ketoacidosis
A recent study found that continuous glucose monitors could help improve patient comfort, reduce resource use, and improve outcomes.
